Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Potent, orally active ACAT inhibitors from Sankyo

April 24, 1997

Azko Nobel discloses antiglucocorticoids

April 24, 1997

Antioxidants/hypolipidemics from ADIR

April 24, 1997

Ono discloses ICE inhibitors

April 23, 1997

New agents for postmenopausal syndrome described by Lilly

April 23, 1997

Gensia Sicor and Sankyo collaborate in diabetes research

April 22, 1997

New selective estrogen receptor modulator from Lilly

April 22, 1997

Pfizer discovers potent, selective beta3-adrenoceptor full agonist

April 22, 1997

Astra Arcus develops selective CCK-A agonist with potential for obesity

April 22, 1997

First launch for Lipobay

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...